Table 2 PFAA profile and identified factors by infectious status
Variables | The group with infection in T2DM (n = 109) | The group without infection in T2DM (n = 923) | p | q |
|---|---|---|---|---|
Mean ± SD/Median(IQR) | Mean ± SD/Median (IQR) | |||
Phe, µmol/L | 55.0 ± 28.0 | 47.1 ± 14.4 | 0.000 | 0.000 |
Hcy, µmol/L | 8.0 ± 0.9 | 7.6 ± 1.1 | 0.001 | 0.007 |
Pro, µmol/L | 416.0 ± 200.5 | 480.1 ± 201.5 | 0.002 | 0.012 |
Asn, µmol/L | 71.3 ± 20.4 | 78.6 ± 24.4 | 0.003 | 0.014 |
Cit, µmol/L | 19.7 ± 7.8 | 21.8 ± 10.4 | 0.039 | 0.120 |
Val, µmol/L | 133.0 ± 42.0 | 142.0 ± 41.0 | 0.039 | 0.120 |
Leu, µmol/L | 124.5 ± 39.8 | 134.0 ± 47.5 | 0.044 | 0.120 |
Gly, µmol/L | 234.3 ± 99.1 | 216.1 ± 89.6 | 0.047 | 0.120 |
His, µmol/L | 71.7 ± 46.5 | 63.4 ± 44.6 | 0.068 | 0.142 |
Asp, µmol/L | 32.6 ± 15.5 | 30.2 ± 12.7 | 0.077 | 0.148 |
Orn, µmol/L | 18.0(12.4–24.3) | 17.4(13.2–23.5) | 0.613 | 0.742 |
Ala, µmol/L | 122.7 ± 54.9 | 130.0 ± 43.0 | 0.108 | 0.191 |
Met, µmol/L | 17.4 ± 6.5 | 18.4 ± 6.6 | 0.12 | 0.197 |
Glu, µmol/L | 109.7 ± 36.4 | 104.1 ± 36.3 | 0.13 | 0.199 |
Gln, µmol/L | 6.1(4.7–8.5) | 7.0(5.2–9.3) | 0.057 | 0.131 |
Pip, µmol/L | 126.0(97.5-177.3) | 128.0(94.5-174.2) | 0.919 | 0.919 |
Trp, µmol/L | 49.7 ± 14.3 | 48.4 ± 14.1 | 0.358 | 0.511 |
Thr, µmol/L | 27.2 ± 14.7 | 26.3 ± 9.8 | 0.383 | 0.511 |
Arg, µmol/L | 11.9 ± 8.0 | 12.7 ± 9.1 | 0.400 | 0.511 |
Tyr, µmol/L | 47.6 ± 17.9 | 48.4 ± 16.3 | 0.669 | 0.769 |
Lys, µmol/L | 143.3 ± 68.6 | 141.1 ± 78.5 | 0.779 | 0.814 |
Ser, µmol/L | 51.4(41.9–66.2) | 51.7(43.1–64.2) | 0.761 | 0.814 |
Cys, µmol/L | 1.5(1.2-2.0) | 1.2(0.9–1.7) | 0.000 | 0.000 |